| Announce Date | 12/26/2025 |
| EPS Normalized Actual | $-0.32429 (Beat by $1.15571) |
| EPS GAAP Actual | $-0.32429 (Beat by $1.15571) |
| Revenue Actual | $0.0142483B |
| Revenue Surprise | Beat by $14.2483M |
| Announce Date | 03/30/2026 (Pre-Market) |
| EPS Normalized Estimate | $-0.19 |
| EPS GAAP Estimate | $-0.19 |
| Revenue Estimate | $0.013198651B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2026 | -0.49 | -1.63 | -0.49 | -0.49 | 1 |
| Dec 2025 | 0.1 | 8 | 0.1 | 0.1 | 0 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | -0.27 | -0.06 | 0.0142483B | -6.34% | -4.25M |
| FQ2 2025 (Jun 2025) | -0.32 | -0.01 | 0.0109675B | -44.45% | -6.03M |
| FQ1 2025 (Mar 2025) | -0.48 | -0.13 | 0.00757566B | -94.1% | -8.92M |
| FQ4 2024 (Dec 2024) | 0 | 0.3 | 0.015857B | 15.32% | -1.14M |
| FQ3 2024 (Sep 2024) | -0.46 | -0.06 | 0.015152B | 3.13% | -1.35M |
| FQ2 2024 (Jun 2024) | -0.71 | -2.05259 | 0.015843B | 12.28% | -11.95M |
| FQ1 2024 (Mar 2024) | -1.87 | -3.44645 | 0.014704B | -0.85% | -22.03M |
| FQ4 2023 (Dec 2023) | -3.59 | -3.59 | 0.013428B | 100% | 13.43M |
FQ4 Announce Date
03/30/2026 (Pre-Market)
Consensus EPS Estimates
-0.19
Consensus Revenue Estimates
0.013198651B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2026 (Dec 2026) | -0.05 | -- | -0.05 | -0.05 | 1 |
| FQ3 2026 (Sep 2026) | -0.14 | -92.86 | -0.14 | -0.14 | 1 |
| FQ2 2026 (Jun 2026) | -0.11 | -190.91 | -0.11 | -0.11 | 1 |
| FQ1 2026 (Mar 2026) | -0.19 | -152.63 | -0.19 | -0.19 | 1 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2026 (Dec 2026) | 0.01B | -- | 0.01B | 0.01B | 1 |
| FQ3 2026 (Sep 2026) | 0.01B | -13.73 | 0.01B | 0.01B | 1 |
| FQ2 2026 (Jun 2026) | 0.01B | 14.71 | 0.01B | 0.01B | 1 |
| FQ1 2026 (Mar 2026) | 0.01B | 42.6 | 0.01B | 0.01B | 1 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
1
EPS # of Misses
7
EPS # of in-lines
0
Revenue # of Beats
1
Revenue # of Misses
7
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | -0.21 | -0.27 | -0.06 | 22.22% |
| FQ2 2025 (Jun 2025) | -0.31 | -0.32 | -0.01 | 3.13% |
| FQ1 2025 (Mar 2025) | -0.35 | -0.48 | -0.13 | 27.08% |
| FQ4 2024 (Dec 2024) | -0.3 | 0 | 0.3 | INF% |
| FQ3 2024 (Sep 2024) | -0.4 | -0.46 | -0.06 | 13.04% |
| FQ2 2024 (Jun 2024) | 1.34259 | -0.71 | -2.05259 | 289.1% |
| FQ1 2024 (Mar 2024) | 1.57645 | -1.87 | -3.44645 | 184.3% |
| FQ4 2023 (Dec 2023) | -3.59 | -3.59 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | $0.02B | $0.01B | $-4.25M | -29.84% |
| FQ2 2025 (Jun 2025) | $0.02B | $0.01B | $-6.03M | -55% |
| FQ1 2025 (Mar 2025) | $0.02B | $0.01B | $-8.92M | -117.8% |
| FQ4 2024 (Dec 2024) | $0.02B | $0.02B | $-1.14M | -7.21% |
| FQ3 2024 (Sep 2024) | $0.02B | $0.02B | $-1.35M | -8.9% |
| FQ2 2024 (Jun 2024) | $0.03B | $0.02B | $-11.95M | -75.45% |
| FQ1 2024 (Mar 2024) | $0.04B | $0.01B | $-22.03M | -149.83% |
| FQ4 2023 (Dec 2023) | $0B | $0.01B | $13.43M | 100% |